A typical drugstore probiotic aisle has 40 to 60 products, each promising digestive health, immune support, or gut balance. Almost all are sold and compared on a single number: CFU, the colony-forming unit count. The CFU number is largely irrelevant on its own. The strain is what matters, and most products bury the strain detail in small print or omit it entirely. This guide walks through the strains with actual clinical evidence in 2026, what each is studied for, and how to read a probiotic label without being misled by big numbers. Discuss any probiotic choice with your doctor, particularly if you have a chronic condition.
Genus, species, strain: the three-part name
A probiotic organism has a three-part name that is essential for evaluation:
- Genus (always capitalized, often abbreviated): Lactobacillus, Bifidobacterium, Saccharomyces, Streptococcus, Bacillus.
- Species (lowercase, italicized): rhamnosus, acidophilus, infantis, boulardii, coagulans.
- Strain (alphanumeric code unique to the manufacturer or research group): GG, NCFM, 35624, CNCM I-745, BC30.
The combination of all three is what matters. Lactobacillus rhamnosus GG and Lactobacillus rhamnosus GR-1 are both L. rhamnosus, but they have different clinical evidence and behave differently in the gut. A label that says only “L. rhamnosus” without a strain code is essentially uninterpretable.
The exception is Saccharomyces boulardii, which is a yeast rather than a bacterium and where most clinical evidence applies to a single strain (CNCM I-745) sold under the brand name Florastor.
Strains with the strongest evidence
A working short list of strains backed by multiple randomized trials in 2026:
Saccharomyces boulardii CNCM I-745. Best evidence for preventing antibiotic-associated diarrhea (around 50 percent risk reduction in meta-analyses) and for preventing recurrent Clostridioides difficile infection alongside standard treatment. Typical dose 5 to 10 billion CFU per day. Shelf-stable as a sporulated yeast.
Lactobacillus rhamnosus GG (LGG). Reasonable evidence for acute infectious diarrhea in children (shorter duration), antibiotic-associated diarrhea, and travelers’ diarrhea prevention. Typical dose 10 to 20 billion CFU per day. The most widely studied probiotic strain overall.
Bifidobacterium infantis 35624 (sold as Align). The strongest evidence in the multi-strain probiotic market for irritable bowel syndrome (IBS). Studies show modest but consistent reduction in bloating, gas, and abdominal pain. Typical dose 1 billion CFU per day.
VSL#3 (now sold under the brand Visbiome in the US). An eight-strain blend with evidence for ulcerative colitis maintenance and pouchitis. Used as adjunctive therapy under gastroenterologist guidance. High dose (300 to 900 billion CFU per day in trials).
Lactobacillus reuteri DSM 17938. Evidence for infant colic in breastfed babies and acute pediatric diarrhea. Typical infant dose 100 million CFU per day.
Lactobacillus acidophilus NCFM and Bifidobacterium lactis Bi-07. Studied together in trials, modest evidence for general digestive symptoms and immune endpoints.
Bacillus coagulans GBI-30 6086 (BC30). A spore-forming strain stable at room temperature, with evidence for general digestive comfort and a separate body of evidence in athletes for protein utilization.
The list above is not exhaustive. It is the set of strains with at least two independent randomized trials in 2026 and a specific indication.
Strains without strong evidence
Many products feature long lists of strains with no published clinical evidence. A 15-strain blend at 50 billion CFU sounds impressive but typically reflects manufacturing choices rather than therapeutic design. The strains chosen are often:
- Older Lactobacillus strains that are easy to grow and stable, with no specific clinical trial backing
- “Soil-based” Bacillus strains that some marketers promote as more natural, with thin clinical evidence in humans
- Combinations chosen for shelf appeal rather than for a specific symptom
A multi-strain blend is not automatically worse than a single-strain product, but the question to ask is whether any of the strains in the blend have evidence for what you are trying to achieve.
Reading a probiotic label correctly
Five things to look for on the label:
Strain identification with alphanumeric code. “Lactobacillus rhamnosus GG” is meaningful. “Lactobacillus rhamnosus proprietary blend” is not.
CFU at expiration, not at manufacture. Reputable products guarantee the CFU through the printed expiration date, not just at the moment of manufacture. The label should say “at expiration” or “through best by date.”
CFU per strain, not total. A label saying “50 billion CFU total across 12 strains” leaves the per-strain dose unclear. A label saying “20 billion CFU L. rhamnosus GG, 10 billion CFU L. acidophilus NCFM” is informative.
Storage requirements. Shelf-stable or refrigerated, both can be fine, but the storage should match the strain biology.
Third-party testing. USP Verified, NSF, ConsumerLab seals indicate that someone other than the manufacturer has checked the contents.
Choosing for a specific situation
Antibiotic-associated diarrhea prevention: Saccharomyces boulardii CNCM I-745 or Lactobacillus rhamnosus GG, started on day 1 of antibiotics and continued for 1 to 2 weeks after.
IBS with bloating and gas: Bifidobacterium infantis 35624 for at least 4 weeks. If no improvement, the strain is unlikely to help and trying a different evidence-backed strain is reasonable.
Travelers’ diarrhea prevention: Saccharomyces boulardii or Lactobacillus rhamnosus GG, started 2 to 3 days before travel and continued through the trip.
General digestive maintenance with no specific symptom: the case for daily probiotic supplementation in healthy adults is weak. A diet with fermented foods (yogurt, kefir, sauerkraut, kimchi) and adequate fiber is at least as well supported by evidence.
Inflammatory bowel disease: do not self-medicate. Talk to your gastroenterologist. Some IBD patients benefit from specific probiotics, but the choice and dose are clinical decisions.
When to avoid probiotics
Probiotics are generally safe but not for everyone. Avoid or use only with explicit medical guidance if you are:
- Severely immunocompromised (chemotherapy, transplant, advanced HIV)
- Critically ill in a hospital setting
- Carrying a central venous catheter
- Recovering from major abdominal surgery
- Diagnosed with short bowel syndrome
- A premature or low-birth-weight infant
Rare bloodstream infections (bacteremia, fungemia) have been reported in these populations from translocation of probiotic organisms across compromised gut barriers.
Talk to your doctor
Probiotics are not benign in every situation, and the choice of strain and dose is more clinical than the over-the-counter market suggests. Bring the product label to your appointment, particularly if you are considering long-term use, are pregnant, are taking immunosuppressants, or have a chronic gastrointestinal condition. Your doctor can tell you whether a specific product is likely to help, harm, or do nothing for your situation.
Frequently asked questions
What is the best probiotic strain to take?+
It depends entirely on what you are trying to address. There is no single best strain. Saccharomyces boulardii CNCM I-745 has strong evidence for preventing antibiotic-associated diarrhea. Lactobacillus rhamnosus GG has evidence for acute pediatric diarrhea. Bifidobacterium infantis 35624 has evidence for irritable bowel syndrome symptoms. A general daily probiotic with no clinical target has weaker evidence. Discuss your goals with your doctor before choosing a probiotic.
Is a higher CFU count always better?+
No. CFU (colony-forming units) measures how many live organisms are in a dose, but it does not tell you which strain or whether the strain you are taking has evidence for what you need. A 5 billion CFU dose of a clinically studied strain is more useful than a 100 billion CFU dose of a strain mix with no studies behind it. Many of the most well-studied strains were tested in trials at 1 to 10 billion CFU per day, not at the 50 to 100 billion doses common on store shelves.
Are probiotics safe to take daily?+
For most healthy adults, yes. Common reported side effects are gas and bloating in the first 1 to 2 weeks as the gut adjusts. People with weakened immune systems (chemotherapy, transplant recipients, advanced HIV, critically ill patients), short bowel syndrome, or central venous catheters should avoid probiotics unless their doctor specifically recommends them, because rare bloodstream infections have been documented in these populations. Pregnant or nursing women, infants, and people with chronic illnesses should talk to their doctor before starting.
How long does a probiotic take to work?+
Depends on the condition. For acute diarrhea (antibiotic-associated, traveler's, or infectious), evidence-supported strains show effects within 24 to 72 hours. For IBS symptom relief, studies typically allowed 4 to 8 weeks. For atopic conditions or general immune effects, trials run 8 to 12 weeks. If you have not noticed a meaningful change after 6 to 8 weeks for a chronic indication, the strain is probably not working for you. Talk to your doctor about next steps.
Do refrigerated probiotics work better than shelf-stable?+
Not inherently. The refrigerated requirement depends on the strain. Some strains are sensitive to heat and humidity and need refrigeration to maintain potency. Other strains are formulated with desiccants or in sporulated form (like Saccharomyces boulardii or Bacillus coagulans) that are stable at room temperature. The label should match the storage to the strain. A shelf-stable product from a reputable manufacturer with a clinically studied strain is fine. A refrigerated product with an obscure strain mix is not automatically better.
Priya Sharma
Priya Sharma writes for The Tested Hub.